The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry.
Abstract
BACKGROUND: Percutaneous balloon aortic valvuloplasty has been used as a therapeutic option for relief of valvular stenosis. This study describes patients undergoing initial percutaneous aortic balloon valvuloplasty enrolled in the National Heart, Lung, and Blood Institute (NHLBI) Balloon Valvuloplasty Registry. METHODS AND RESULTS: Extensive baseline procedural and postprocedural data were tabulated in 674 patients during a 24-month period. Functional status was captured using standard methods and an overall functional scoring system. Complications were defined and divided into procedural, acute (within 24 hours), in-hospital, and within 30 days of the procedure. The patient population was elderly and symptomatic, with 83% greater than 70 years of age. New York Heart Association functional class (FC) III or IV congestive heart failure (CHF) was present in 76%, syncope or presyncope was present in 34%, and Canadian Heart Association class III or IV angina was present in 23%. Using an overall functional scoring system (0-100), 54% exhibited scores less than 50. Comorbid disease was common. Forty-five percent possessed at least one serious noncardiac disability as a reason for valvuloplasty. Eighty percent of those seen by a cardiothoracic surgeon were believed inappropriate for aortic valve replacement. Hemodynamically, the aortic valve area increased from 0.5 +/- 0.2 cm2 to 0.8 +/- 0.3 cm2 (p less than 0.0001), accompanied by a fall in mean and peak aortic valve gradient from 55 +/- 21 and 65 +/- 28 mm Hg to 29 +/- 13 and 31 +/- 18 mm Hg, respectively (both p less than 0.0001). Small but significant increases were observed in cardiac output, heart rate, and mean aortic pressure with minor declines in the pulmonary artery (PA) systolic and left ventricular (LV) end-diastolic pressure. One hundred sixty-seven (25%) experienced at least one significant complication within 24 hours, and 211 (31%) experienced a significant complication before discharge. Complications before hospital discharge included the need for transfusion (23%), vascular surgery (7%), cerebrovascular accident (3%), other systemic embolus (2%), myocardial infarction (2%), acute tubular necrosis (1%), or cardiac surgery (1%). Seventeen (3%) patients died during the procedure; 16 of those were due to cardiac causes. By hospital discharge, there was an additional 52 total deaths; 37 were due to cardiovascular causes. Between hospital discharge and 30 days, 23 additional deaths occurred; 18 were due to cardiac disease. At 30 days, therefore, there was a grand total of 92 (14%) deaths; 71 (11%) were due to cardiovascular-related causes. Univariate and logistic regression analysis of mortality revealed that death was most frequent in patients suffering multiorgan failure and poor LV systolic function. Thirty-day mortality was associated with a predefined high-risk subset of hypotension and NYHA class IV CHF (risk ratio, 4.4), blood urea nitrogen (BUN) greater than 30 mg/dl (risk ratio, 3.7), use of an antiarrhythmic (risk ratio, 2.9), and cardiac output less than 3.0 l/min (risk ratio, 2.4). Of the survivors (86%) at 30 days, symptomatic improvement was generally present. Seventy-five percent experienced at least one functional class improvement in CHF, and 53% experienced at least a quartile improvement in overall functional status score. CONCLUSIONS: These data reveal that percutaneous aortic balloon valvuloplasty in an elderly and debilitated population can be done with low mortality but substantial morbidity. Mortality is greatest in patients with multiorgan failure resulting from poor cardiac output. In patients with reasonably preserved LV function who are otherwise inappropriate surgical candidates because of comorbid factors, survival and early improvement in symptomatic status are frequently observed after percutaneous aortic valvuloplasty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gorlin, R., & Gorlin, S. G. (1951) · American Heart Journal · doi:10.1016/0002-8703(51)90002-6 · Cited by 1,778
Letter: Grading of angina pectoris.
Campeau, L. (1976) · Circulation · doi:10.1161/circ.54.3.947585 · Cited by 1,601
Left retrograde cardioangiography in acquired cardiac disease
Sellers, R. D., Levy, M. J., Amplatz, K., & Lillehei, C. W. (1964) · The American Journal of Cardiology · doi:10.1016/0002-9149(64)90027-x · Cited by 800
Cribier, A., Saoudi, N., Berland, J., Savin, T., Rocha, P., & Letac, B. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90716-6 · Cited by 668
Functional Status Questionnaire
Sisto, S. A. (2017) · Encyclopedia of Clinical Neuropsychology · doi:10.1007/978-3-319-56782-2_1938-2 · Cited by 449
Percutaneous balloon aortic valvuloplasty: Results in 23 patients
Lababidi, Z., Wu, J.-R., & Walls, J. T. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90709-4 · Cited by 433
Free radicals and myocardial injury: pharmacologic implications.
Werns, S. W., Shea, M. J., & Lucchesi, B. R. (1986) · Circulation · doi:10.1161/01.cir.74.1.1 · Cited by 295
Balloon Aortic Valvuloplasty in 170 Consecutive Patients
Safian, R. D., Berman, A. D., Diver, D. J., McKay, L. L., Come, P. C., Riley, M. F., Warren, S. E., Cunningham, M. J., Wyman, R. M., Weinstein, J. S., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190301 · Cited by 233
Natural History of Candidates for Balloon Aortic Valvuloplasty
O'KEEFE, J. H., VLIETSTRA, R. E., BAILEY, K. R., & HOLMES, D. R. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65068-x · Cited by 178
McKay, R. G. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80120-2 · Cited by 167
Cited by
2012 ACCF/AATS/SCAI/STS Expert Consensus Document on Transcatheter Aortic Valve Replacement
Holmes, D. R., Mack, M. J., Kaul, S., Agnihotri, A., Alexander, K. P., Bailey, S. R., Calhoon, J. H., Carabello, B. A., Desai, M. Y., Edwards, F. H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.001 · Cited by 749
Transcatheter aortic valve implantation: first results from a multi-centre real-world registry
Zahn, R., Gerckens, U., Grube, E., Linke, A., Sievert, H., Eggebrecht, H., Hambrecht, R., Sack, S., Hauptmann, K. E., Richardt, G., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq339 · Cited by 596
Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival
Lieberman, E. B., Bashore, T. M., Hermiller, J. B., Wilson, J. S., Pieper, K. S., Keeler, G. P., Pierce, C. H., Kisslo, K. B., Harrison, J. K., & Davidson, C. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00363-0 · Cited by 299
Complications and Outcome of Balloon Aortic Valvuloplasty in High-Risk or Inoperable Patients
Ben-Dor, I., Pichard, A. D., Satler, L. F., Goldstein, S. A., Syed, A. I., Gaglia, M. A., Weissman, G., Maluenda, G., Gonzalez, M. A., Wakabayashi, K., et al. (2010) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.08.014 · Cited by 279
Outcomes of Inoperable Symptomatic Aortic Stenosis Patients Not Undergoing Aortic Valve Replacement
Kapadia, S., Stewart, W. J., Anderson, W. N., Babaliaros, V., Feldman, T., Cohen, D. J., Douglas, P. S., Makkar, R. R., Svensson, L. G., Webb, J. G., et al. (2015) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.08.015 · Cited by 62
Metadata
- Venue
- Circulation
- Published
- 1991-12
- Volume
- 84
- Issue
- 6
- Pages
- 2383-2397
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2605849282
- Cited by
- 353
- References
- 20
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. https://app.cochat.ai/papers/10.1161/01.cir.84.6.2383
- The paper
- Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. (1991). Circulation. https://doi.org/10.1161/01.cir.84.6.2383
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.